Second-quarter revenue amounted to CHF 707.0 million, with organic growth accelerating to 8.5%; half-year revenue reached CHF 1.4 billion, representing 7.8% organic growth Core EBIT margin improved to 26.9% at constant 2025 exchange rates, or 25.7% including currency effects Continued market share gains in premium implantology, with iEXCEL drivin [ … ]

Basel, 19 August 2026: Straumann Group today announced the appointment of Christopher Norbye as Chief Executive Officer, effective on 1st of December, as part of a planned leadership transition. He will succeed Guillaume Daniellot, who has decided to step down after almost 20 years with the company, including seven years as CEO.   Petra Rumpf, Ch [ … ]

Group revenue reached CHF 673 million in the first quarter, representing 7.1% organic growth, reflecting a strong start to the year Continued leadership building in implantology, driven by strong iEXCEL momentum, ongoing global expansion of Neodent and the support of the recent launch of AOMI, a new global clinical specialized expert network in im [ … ]

Straumann Holding AG / Key word(s): AGMEGM Straumann Group shareholders approve all proposals 17.04.2026 / 15:56 CET/CEST Basel, April 17, 2026: Today at the Annual General Meeting (AGM) of Straumann Holding AG, the Straumann shareholders approved all proposals put forward by the Board of Directors. The meeting was at [ … ]